Oragenics Inc OGEN:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EDT
0.72quote price arrow up+0.02 (+2.71%)
Volume
28,649
Close
0.70quote price arrow down-0.0019 (-0.2707%)
Volume
2,122,229
52 week range
0.38 - 2.09

...

Loading . . .
  • Open0.71
  • Day High0.71
  • Day Low0.685
  • Prev Close0.7019
  • 52 Week High2.09
  • 52 Week High Date07/22/20
  • 52 Week Low0.38
  • 52 Week Low Date11/23/20

Key Stats

  • Market Cap80.95M
  • Shares Out115.64M
  • 10 Day Average Volume2.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change55.9

KEY STATS

  • Open0.71
  • Day High0.71
  • Day Low0.685
  • Prev Close0.7019
  • 52 Week High2.09
  • 52 Week High Date07/22/20
  • 52 Week Low0.38
  • 52 Week Low Date11/23/20
  • Market Cap80.95M
  • Shares Out115.64M
  • 10 Day Average Volume2.60M
  • Dividend-
  • Dividend Yield-
  • Beta0.28
  • YTD % Change55.9

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-1.64
  • Fwd P/E (NTM)-3.41
  • EBITDA (MRQ)-26.596M
  • ROE (MRQ)-135.26%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.32%

EVENTS

  • Earnings Date08/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oragenics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have...
Frederick Telling Ph.D.
Chairman
Michael Sullivan CPA
Chief Executive Officer
Address
4902 Eisenhower Blvd Ste 125
Tampa, FL
33634-6342
United States

Top Peers

SYMBOLLASTCHG%CHG
MITO
Stealth BioTherapeutics Corp
1.50-0.03-1.96%
SYN
Synthetic Biologics Inc
0.6171+0.0007+0.11%
BCDA
BioCardia Inc
4.86-0.04-0.82%
ELOX
Eloxx Pharmaceuticals Inc
1.93-0.15-7.21%
SLNO
Soleno Therapeutics Inc
1.07-0.01-0.93%